Michelle Lockley Selected Research

Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)

1/2021

The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle Lockley Research Topics

Disease

21	Neoplasms (Cancer) 11/2023 - 09/2006
15	Ovarian Neoplasms (Ovarian Cancer) 09/2023 - 01/2006
11	Carcinoma (Carcinomatosis) 01/2022 - 01/2006
4	Teratoma (Teratoid Tumor) 04/2022 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2016
3	Infections 01/2016 - 03/2011
2	Seminoma 01/2023 - 01/2022
2	Inflammation (Inflammations) 01/2016 - 07/2015
1	Confusion (Bewilderment) 03/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Ototoxicity 10/2023
1	Dysgerminoma 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Pulmonary Embolism 11/2021
1	Venous Thromboembolism 11/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Endometrial Neoplasms (Endometrial Cancer) 01/2018
1	Disease Progression 01/2018
1	Tertiary Lymphoid Structures 10/2016
1	Ascites 07/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2011

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2010
4	CytokinesIBA 01/2022 - 03/2011
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2024 - 01/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023 - 10/2016
2	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2022
2	Cell-Free Nucleic AcidsIBA 07/2023 - 08/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2021
2	PlatinumIBA 01/2021 - 01/2021
2	AntigensIBA 01/2021 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 04/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 04/2011
2	dl1520 (ONYX-015)IBA 04/2015 - 01/2006
1	Carvedilol (Coreg)FDA LinkGeneric 01/2022
1	ArrestinsIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	chloroxine FDA Link 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	rucaparibIBA 10/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	IntegrinsIBA 07/2015
1	cyclic arginine-glycine-aspartic acid peptideIBA 07/2015
1	Junctional Adhesion Molecule CIBA 10/2013
1	Dihydrotachysterol (AT 10)IBA 10/2013
1	Messenger RNA (mRNA)IBA 09/2012
1	Checkpoint Kinase 1IBA 04/2011
1	Infliximab (Remicade)FDA Link 03/2011
1	Interleukin-6 (Interleukin 6)IBA 03/2011
1	Renilla LuciferasesIBA 09/2006
1	alovudineIBA 09/2006
1	thymidine kinase 1IBA 09/2006
1	Viral ProteinsIBA 01/2006
1	Icodextrin (Extraneal)FDA Link 01/2006
1	LuciferasesIBA 01/2006

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 07/2023 - 04/2015
9	Therapeutics 11/2023 - 01/2014
6	Neoadjuvant Therapy 11/2021 - 08/2015
2	Salpingo-oophorectomy 01/2023 - 04/2022
2	Cytoreduction Surgical Procedures 11/2021 - 01/2021
2	Adjuvant Chemotherapy 01/2021 - 01/2020
1	Cystectomy 04/2022
1	Radiotherapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2022
1	Treatment Delay 11/2021
1	Vena Cava Filters (Inferior Vena Cava Filter) 11/2021